Ledger.Open graph →
SEC Form D · filed February 3, 2020

Inflammatix, Inc

Offering
$32.1M
Sold
$32.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BURLINGAME, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Steven Tablak · BURLINGAME, CADirectorKenneth Bahk · BURLINGAME, CADirectorMichael Rubin · BURLINGAME, CADirectorDavid Persing · BURLINGAME, CADirectorTimothy Sweeney · BURLINGAME, CAExec · DirectorJonathan Romanowsky · BURLINGAME, CAExecSC Management LLC Management SC Management SC SC Management LLC · New York, NYExec · DirectorSC Management LLC Management SC Management SC Management LLC · New York, NYDirectorAusten Helfrich · Salt Lake City, UTDirectorJason M. Stein · Brooklyn, NYDirectorKyle White · Salt Lake City, UTDirectorThejas Nalval · Hoboken, NJExec · DirectorAcies Management LLC · Markham, ILDirectorJingjing Zhang · Markham, ILDirectorNed Mahic · Markham, ILDirectorArnold Kozys · Markham, ILDirectorJonathan Romanowsky · BURLINGAME, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗